Advancing All-Payer Health Equity Approaches and Development (AHEAD)

Strategic questions for your team

Given that AHEAD imposes two-sided risk arrangements with statewide or sub-state Total Cost of Care (TCOC) targets accountable across all Original Medicare FFS beneficiaries, does our organization have the actuarial modeling capability and financial reserves to absorb downside risk exposure starting January 1, 2028 (Cohorts 2 and 3) through December 31, 2035 — and have we stress-tested our balance sheet against a scenario where TCOC targets are missed in the first two performance years?
For hospitals specifically: Can our organization operationally transition from volume-based fee-for-service revenue to a prospective annual Medicare FFS global budget that covers both inpatient and outpatient services, and do we have the care coordination infrastructure — including post-acute partnerships and ambulatory relationships — to eliminate avoidable hospitalizations that a global budget financially incentivizes us to prevent?
For primary care practices evaluating PC AHEAD: Which of the four payment pathways is financially optimal for our practice given our current patient population's medical and social complexity, and are we prepared to accept prospective, risk-adjusted Enhanced Primary Care Payments (including quality-based adjustments) in lieu of part or all of corresponding Medicare FFS payments under the two prospective-payment pathways — and what is the revenue variance risk if our risk-adjustment scores are recalibrated?
Does our organization have the multi-payer contract renegotiation capacity and state-level relationships required to align Medicaid and commercial payer arrangements with the Medicare TCOC framework — and are our existing Medicaid contracts with the state Medicaid agency compatible with the Medicaid transformation methodology alignment requirements that AHEAD mandates for participating primary care practices and hospitals?
If we are an ACO, integrated delivery system, or large physician group considering applying as a Geo Entity: Are we positioned to compete in AHEAD's competitive bidding process for Geo Entity selection (CMS selects at least two per state or sub-state region), and do we have the network breadth, attribution management capability, and care management infrastructure to assume TCOC and quality accountability for previously unattributed Medicare FFS beneficiaries assigned through voluntary, claims-based, and geographic attribution methods?
What is the realistic population health data and analytics infrastructure required to track statewide or sub-state quality targets for all residents — including whole-person and social determinants of health metrics — and does our current technology stack support prospective risk-adjustment, real-time attribution monitoring, and quality performance reporting at the scale AHEAD demands across the full 2028–2035 performance window?
Given that AHEAD's model design explicitly advances beneficiary choice and competition by requiring at least two competing Geo Entities per state/region, what is our competitive positioning relative to other health systems, ACOs, and regional provider networks in our state (Maryland, Connecticut, Hawaii, Rhode Island, or New York) — and does Geo AHEAD entry by a competitor pose an existential patient attribution risk to our organization if we do not participate?
Have we quantified the value of CMS cooperative agreement funding available during the pre-implementation period for planning activities, and does our organization have the grant management infrastructure and state-level partnership relationships to maximize this funding to offset the significant operational build-out costs of AHEAD participation before the January 1, 2028 performance period begins?
For primary care practices: Are we prepared to meet the mandatory requirement to engage in state-led Medicaid transformation efforts that align with the Medicare PC AHEAD program — and have we assessed whether our current Medicaid patient panel size, payer mix, and state Medicaid agency relationships make this dual-track transformation requirement a net operational asset or a resource constraint?
Given that AHEAD runs through December 31, 2035 and the September 2025 policy and operational changes already restructured cohort timelines, what is our organization's risk tolerance for a decade-long contractual commitment to a voluntary CMMI model under the current Trump administration's CMS leadership — including CMMI Director Abe Sutton and CMS Administrator Dr. Mehmet Oz — and have we modeled the financial impact of potential future model modifications, early termination, or policy pivots on our long-term strategic plan?

Traps and concerns

Global Budget Revenue Lock-In vs. Volume Volatility
Hospitals operating under AHEAD's prospective Medicare FFS global budgets face a structural payment/reconciliation trap: budgets are set annually in advance, but actual patient volume and acuity fluctuate unpredictably. If a hospital experiences an unexpected surge in high-acuity admissions—driven by a flu outbreak, natural disaster, or demographic shift—its fixed global budget will not automatically adjust upward, compressing margins on a per-case basis. Conversely, if volume drops below projections (the intended goal of better care coordination), the hospital still bears the operational cost of its fixed infrastructure against a budget calibrated to prior utilization. The methodology includes quality and health outcomes adjustments, but these adjustment mechanisms operate on a performance cycle that lags real-time volume changes by months or more. Hospitals that fail to model multiple volume scenarios before accepting their global budget offer—and that lack robust intra-year financial dashboards tracking run-rate against budget—risk mid-year cash flow crises with no fee-for-service revenue backstop.
Multi-Payer Alignment Failure Stranding Medicare Savings
AHEAD's core theory of change requires state Medicaid agencies and commercial payers to align with Medicare's total cost of care (TCOC) targets and primary care investment methodology. However, alignment is not contractually mandated for commercial payers—it depends on state regulatory authority and voluntary cooperation. If a state achieves Medicare FFS savings but Medicaid and commercial payers do not synchronize payment rates, care management protocols, or attribution logic, providers face continued administrative fragmentation across payer lines. This undermines the financial case for the care model investments (e.g., enhanced primary care staffing, population health infrastructure) that only pencil out when amortized across all payer revenue streams. States with politically constrained Medicaid agencies or limited insurance regulatory leverage—such as states with large self-insured employer populations exempt from state insurance mandates under ERISA—face particular exposure. The cooperative agreement funding provided by CMS for pre-implementation planning does not guarantee commercial payer participation, leaving a potentially large revenue alignment gap.
PC AHEAD Pathway Selection Locking Practices Into Wrong Risk Tier
Primary care practices must choose from four PC AHEAD payment pathways offering different levels of financial risk, care transformation requirements, and payment flexibility—including two pathways offering prospective payments in lieu of part or all of corresponding Medicare FFS payments. Practices that select a prospective payment pathway to gain revenue predictability surrender the volume-based FFS safety net. If their risk-adjusted Enhanced Primary Care Payment is calibrated using baseline attribution data that understates the medical and social complexity of their actual patient panel, the prospective payment will be systematically underfunded. Small or independent primary care practices lacking actuarial expertise to validate CMS's risk-adjustment inputs before pathway selection are particularly exposed. Once locked into a pathway for a performance year, mid-course corrections are constrained, and the financial impact of a miscalibrated risk score compounds annually. With Cohort 2 and 3 performance periods now beginning January 1, 2028, practices in Connecticut, Hawaii, Rhode Island, and New York have a narrow pre-implementation window to audit their patient panel data, challenge attribution assumptions, and model downside scenarios across all four pathways before commitment.
Geo Entity Competitive Bidding Concentration Risk
AHEAD requires CMS to select at least two Geo Entities per state or sub-state region through a competitive bidding process, designed to ensure beneficiary choice and market competition. The regulatory risk is bidirectional: if too few qualified organizations submit competitive bids in a state, CMS may select Geo Entities that lack the network infrastructure, care management capacity, or capital reserves to absorb two-sided TCOC risk at geographic scale. Conversely, dominant health systems that win Geo Entity status gain attribution rights over previously unattributed Medicare FFS beneficiaries through geographic assignment—not just voluntary or claims-based alignment—creating a potential market consolidation dynamic that federal antitrust regulators or state attorneys general could scrutinize. Organizations preparing bids must account for the fact that geographic attribution obligates them to manage cost and quality for a population they did not choose, including high-need beneficiaries with no prior relationship to their network, without the ability to fully predict that population's baseline spend. Geo Entities that underprice their bids to win selection and then discover their attributed population is sicker than modeled face immediate two-sided risk exposure with no structural off-ramp.
State Accountability Target Misalignment Across Cohort Timelines
AHEAD now operates across three cohorts with a unified end date of December 31, 2035, but Cohort 1 (Maryland) has a longer performance track than Cohorts 2 (Connecticut, Hawaii) and 3 (Rhode Island, New York), whose performance periods now begin January 1, 2028 following the September 2025 model redesign. States are accountable for statewide or sub-state TCOC targets across both Medicare FFS and all payers, as well as statewide quality targets for all residents. The compliance risk for Cohort 2 and 3 states is that the January 2026 implementation of new policy and operational changes—applied across all cohorts simultaneously—creates a compressed pre-implementation planning horizon. State Medicaid agencies must align global budget and primary care transformation methodologies with CMS requirements before their 2028 performance start, while simultaneously managing existing Medicaid program obligations. States that fail to execute the Medicaid alignment work during this window will enter their performance period with structural gaps between their Medicare and Medicaid accountability frameworks, potentially triggering performance penalties on statewide quality targets even if Medicare FFS performance is on track.
Attribution Data Infrastructure Gaps Undermining TCOC Measurement
AHEAD's Geo AHEAD component relies on a hybrid attribution system combining voluntary selection, claims-based attribution, and geographic assignment to assign Medicare FFS beneficiaries to Geo Entities. This creates a complex operational and technology risk: Geo Entities must maintain real-time visibility into which beneficiaries are attributed under which methodology, because the cost and quality accountability baseline differs depending on attribution pathway. Claims-based attribution lags by weeks or months, geographic assignment may include beneficiaries who received care entirely outside the Geo Entity's network, and voluntary selection creates an adverse selection risk if healthier beneficiaries opt in while complex patients remain geographically assigned. Provider organizations lacking enterprise-grade data infrastructure capable of ingesting and reconciling CMS attribution files, adjudicated claims feeds, and state Medicaid encounter data will be flying blind on their TCOC performance until after reconciliation deadlines have passed. For hospital participants seeking to collaborate with Geo Entities to amplify shared savings, misaligned patient-level data between the hospital's EHR, the Geo Entity's care management platform, and CMS's attribution system creates both operational blind spots and compliance documentation vulnerabilities during model audits.
Model Redesign Mid-Stream Disrupting Contracted Provider Arrangements
The September 2025 announcement of new policy and operational changes—applied across all cohorts beginning January 2026—demonstrates that AHEAD's model design remains subject to material mid-stream revision under the current CMS leadership and CMMI Director Abe Sutton. Hospitals, primary care practices, and Geo Entities that have executed multi-year contractual arrangements (staffing agreements, vendor contracts, care management platform licenses, Medicaid value-based contracts with state agencies) based on the prior model specifications face financial and legal exposure when CMS unilaterally revises payment methodologies, performance targets, or timeline structures. The shift of Cohort 2 and 3 performance start dates to January 1, 2028 and the new unified end date of December 31, 2035 are consequential changes that alter investment payback horizons and risk-bearing periods. Participants that did not negotiate model-change termination clauses or force majeure provisions tied to material CMS specification revisions into their downstream contracts have limited recourse for absorbing the sunk costs of planning activities undertaken under superseded model rules. With the Trump administration's emphasis on competition, prevention, and taxpayer protection—and ongoing DOGE-driven federal efficiency reviews—further model design changes before 2028 performance periods begin cannot be ruled out.